Michael Tracey Finucan

Michael Finucan practices at BHS Physicians Network, Inc in San Antonio, Texas.

Michael Finucan's NPI, 1609230259, was assigned on April 11, 2016. Michael Finucan graduated from Boonshoft School of Medicine in 2016. Michael Finucan holds Texas license T7214.

Michael Finucan's primary practice is BHS Physicians Network, Inc, at 1935 NE Loop 410, San Antonio, TX 78217 in Bexar County. The practice phone is (207) 323-7336.

Michael Finucan's primary practice is BHS Physicians Network, Inc in San Antonio, Texas. Michael Finucan is also affiliated with Baptist Medical Center. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Michael Finucan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Finucan practices, 2 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Michael Finucan's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Michael Finucan is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Michael Finucan's licenses on file in 3 states: Texas, Georgia and Ohio.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Michael Finucan treats.

CMS data shows 135 Medicare services from Michael Finucan across 5 procedure codes in 2024, for 75 Medicare patients. Medicare paid $13,224 for them.

CMS counts 75 Medicare patients who saw Michael Finucan in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Finucan's median patient age at 63, with 52% women.

In 2024, Michael Finucan wrote 146 Medicare Part D claims for 102 patients. 82% of them were for generic drugs. CMS names the drug for 122 of them, across 5 drugs with 11 or more claims each, at $3,596 in total drug cost. In 2023, CMS named 78 claims across 4 drugs.

Michael Finucan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of colonoscopy by Michael Finucan, more than 50% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Michael Finucan, published from 2012 to 2015. 2013 was the busiest year, with 2. The most frequent topics are Heart Failure, Glomerular Filtration Rate and Creatinine. Michael Finucan has published most often in Eur J Heart Fail. Michael Finucan's most frequent co-authors are Wilfried Mullens, Alaa Gabi, MD and Kevin Lal Shrestha, MD.

CMS Open Payments shows 27 general payments to Michael Finucan from 10 drug and device companies from 2022 to 2025. Education make up the largest share, 75% of the total. Intuitive Surgical, Inc. paid the most, $5,704.

Michael Finucan graduated from Boonshoft School of Medicine in 2016. Michael Finucan is a member of ACS and ASCRS.

Michael Finucan is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.